Isofol Medical AB (publ)
556759-8064ActiveDeveloping next-generation folate drug to improve cancer treatment efficacy.
Overview
- 10–19
- Employees
- ≤1K SEK
- Revenue
- 2008
- Founded
Description
Isofol is a publicly listed biotechnology company focused on advancing cancer care. The organization is dedicated to developing its drug candidate, arfolitixorin, a novel folate-based therapy. Arfolitixorin is specifically designed to enhance the efficacy of standard first-line treatments for severe...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556759806401
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
NUCLITHERA AS
7 employeesDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Exocure Sweden AB
Exocure pioneers exosome biotechnology for advanced cancer therapeutics.
Ambusol AB (publ)
1–4 employeesPioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
BioGaia Pharma AB
0 employeesDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Medivir Aktiebolag
10–19 employeesDeveloping transformative pharmaceutical treatments for unmet cancer needs.
Browse More
Isofol Medical AB (publ) Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo